This survey will close September 9th, 2016.
Epclusa (generic name sofosbuvir / velpatasvir) is being considered for BC PharmaCare coverage. One of the questions BC PharmaCare asks patient groups is:
“What drugs or other treatments have the patients in your group used, or are currently using, for the condition or disease for which this drug is used? Please list all of the treatments used and tell us about the experience of the patients in your group with each treatment.”
In hopes of answering this question well, the Pacific Hepatitis C Network has put together a very quick and easy survey for those of you who have taken treatment for hepatitis C, any treatment for hep C. Please consider completing our survey.
Please Note: Survey responses are anonymous (we don’t know your name or other information about you). The information gathered will be used as part of a patient group input report for BC PharmaCare. By completing the survey you accept that the Pacific Hepatitis C Network can use the information gathered by it in our patient group input report for BC PharmaCare.
Please email the Hepatitis C Treatment Information Project with any comments or concerns you have about Epclusa, the drug approval process, or about this survey.